Travere Therapeutics, Inc. (TVTX)
55.38
-2.29
(-3.97%)
USD |
NASDAQ |
Oct 06, 14:03
Travere Therapeutics Price : 55.38 for Oct. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 05, 2026 | 57.31 | 58.60 | 55.86 | 57.67 | 2.644M |
| Oct 02, 2026 | 57.21 | 57.53 | 56.34 | 56.93 | 1.722M |
| Oct 01, 2026 | 58.64 | 59.58 | 56.23 | 56.85 | 2.395M |
| Sep 30, 2026 | 60.35 | 60.47 | 58.83 | 58.88 | 1.561M |
| Sep 29, 2026 | 61.04 | 61.87 | 59.33 | 59.99 | 1.565M |
| Sep 28, 2026 | 59.05 | 61.75 | 58.71 | 61.57 | 1.235M |
| Sep 25, 2026 | 60.89 | 60.89 | 59.05 | 59.44 | 1.206M |
| Sep 24, 2026 | 60.00 | 60.80 | 59.22 | 60.62 | 1.756M |
| Sep 23, 2026 | 60.39 | 60.89 | 58.32 | 59.83 | 1.714M |
| Sep 22, 2026 | 60.37 | 62.45 | 59.30 | 60.28 | 3.120M |
| Sep 21, 2026 | 63.01 | 63.64 | 61.85 | 62.86 | 1.584M |
| Sep 18, 2026 | 64.89 | 64.89 | 62.47 | 62.76 | 2.236M |
| Sep 17, 2026 | 64.51 | 65.86 | 63.84 | 64.74 | 1.385M |
| Sep 16, 2026 | 62.58 | 64.07 | 62.41 | 63.48 | 2.221M |
| Sep 15, 2026 | 65.31 | 65.32 | 61.40 | 62.51 | 2.098M |
| Sep 14, 2026 | 66.17 | 67.88 | 65.39 | 65.79 | 924718.0 |
| Sep 11, 2026 | 67.76 | 68.73 | 66.11 | 66.17 | 1.150M |
| Sep 10, 2026 | 65.60 | 68.59 | 64.45 | 67.51 | 1.560M |
| Sep 09, 2026 | 65.80 | 68.23 | 65.59 | 66.22 | 1.236M |
| Sep 08, 2026 | 63.86 | 66.54 | 63.48 | 66.07 | 1.361M |
| Sep 04, 2026 | 66.04 | 67.10 | 65.04 | 65.28 | 1.051M |
| Sep 03, 2026 | 67.18 | 68.03 | 66.04 | 66.54 | 1.115M |
| Sep 02, 2026 | 66.37 | 67.82 | 65.76 | 67.23 | 1.086M |
| Sep 01, 2026 | 66.00 | 66.60 | 65.37 | 65.71 | 1.075M |
| Aug 31, 2026 | 65.70 | 66.70 | 65.07 | 66.28 | 1.891M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| BioMarin Pharmaceutical, Inc. | 56.02 |
| TG Therapeutics, Inc. | 51.93 |
| Krystal Biotech, Inc. | 324.46 |
| RenovoRx, Inc. | 1.42 |
| Pelthos Therapeutics, Inc. | 22.27 |
Price Related Metrics
| PS Ratio | 8.856 |
| Price to Book Value | 212.68 |
| Price to Free Cash Flow | 340.09 |
| Earnings Yield | -1.38% |
| Market Cap | 5.215B |